Back to dashboard
CommercialAdministrativeMedium impact

06.02.46a, Rapid Whole Exome Sequencing (rWES) and Rapid Whole Genome Sequencing (rWGS) for Diagnosis of Genetic Disorders

Independence Blue Cross·Oncology, Neurology, Pediatrics +1 more·Medical Policy
Effective date
Dec 19, 2025
We identified it
Jun 19, 2026
Days to comply

Summary

This is a reissue of the existing policy for Rapid Whole Exome Sequencing (rWES) and Rapid Whole Genome Sequencing (rWGS) for diagnosis of genetic disorders. The policy has been reposted with an effective date of December 19, 2025, but no specific content changes are indicated in the summary.

Action Required

Action needed
By December 19, 2025: Billing team should review the complete policy document at the provided URL to identify any changes to coverage criteria, prior authorization requirements, or billing guidelines for rapid whole exome and genome sequencing. Update billing procedures and provider notifications as needed based on the full policy content.